Nurse Anesthetist - CR in Orange, CA Accepting Medicare
42 Nurse Anesthetist - CR nurses found. Showing 41 - 42
 Mr. Jeffrey E Murray, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-880-7812 |
 Ann Mitchell, CRNA, MSN Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-880-7812 |
News Archive
UT Southwestern researchers develop novel chemical reaction that could accelerate drug development
Chemists have long sought to develop new reactions for the direct conversion of simple hydrocarbon building blocks into valuable materials such as pharmaceuticals in a way that dependably creates the same chemical bonds and orientations.
Women double fruit and vegetable intakes with switch to Mediterranean diet
In a new study led by the University of Michigan Health System, women more than doubled their fruit and vegetable intakes and dramatically increased their consumption of "good" fats when they were counseled by registered dietitians and provided with a list of guidelines on the amount of certain foods they should eat each day.
CT imaging can play important role in car crash testing
Crash test injuries analyzed with CT imaging provide valuable data that can help engineers develop safer cars and reduce the severity of injuries during car accidents, according to a new study by researchers from The Ohio State University in Columbus.
AFA reacts to an Ohio woman's claims of an embroyo mix up
An Ohio woman, 40-year-old Carolyn Savage, claims a fertility clinic implanted the wrong embryo and that the baby she's due to deliver the first week in October is not hers. Several media reports state Savage and her husband plan to give the baby boy to his biological parents. The name of the clinic is not being released in this very rare alleged case.
FDA grants orphan drug designation for Synageva BioPharma's SBC-102
Synageva BioPharma Corp., a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration has granted orphan drug designation for SBC-102, the Company's enzyme replacement therapy in development to treat Lysosomal Acid Lipase Deficiency, also known as Wolman Disease and Cholesteryl Ester Storage Disease, a condition for which there is currently no approved treatment.
› Verified 1 days ago